129 related articles for article (PubMed ID: 10382914)
1. Effect of mexiletine on sea anemone toxin-induced non-inactivating sodium channels of rat skeletal muscle: a model of sodium channel myotonia.
Desaphy JF; Camerino DC; Tortorella V; De Luca A
Neuromuscul Disord; 1999 May; 9(3):182-9. PubMed ID: 10382914
[TBL] [Abstract][Full Text] [Related]
2. Increased hindrance on the chiral carbon atom of mexiletine enhances the block of rat skeletal muscle Na+ channels in a model of myotonia induced by ATX.
Desaphy JF; Conte Camerino D; Franchini C; Lentini G; Tortorella V; De Luca A
Br J Pharmacol; 1999 Nov; 128(6):1165-74. PubMed ID: 10578128
[TBL] [Abstract][Full Text] [Related]
3. Loss of Na+ channel inactivation by anemone toxin (ATX II) mimics the myotonic state in hyperkalaemic periodic paralysis.
Cannon SC; Corey DP
J Physiol; 1993 Jul; 466():501-20. PubMed ID: 8105077
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the antimyotonic activity of mexiletine and some new analogs on sodium currents of single muscle fibers and on the abnormal excitability of the myotonic ADR mouse.
De Luca A; Pierno S; Natuzzi F; Franchini C; Duranti A; Lentini G; Tortorella V; Jockusch H; Camerino DC
J Pharmacol Exp Ther; 1997 Jul; 282(1):93-100. PubMed ID: 9223544
[TBL] [Abstract][Full Text] [Related]
5. Stereoselective effects of mexiletine enantiomers on sodium currents and excitability characteristics of adult skeletal muscle fibers.
De Luca A; Natuzzi F; Lentini G; Franchini C; Tortorella V; Conte Camerino D
Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):653-61. PubMed ID: 9053738
[TBL] [Abstract][Full Text] [Related]
6. Mexiletine block of wild-type and inactivation-deficient human skeletal muscle hNav1.4 Na+ channels.
Wang GK; Russell C; Wang SY
J Physiol; 2004 Feb; 554(Pt 3):621-33. PubMed ID: 14608007
[TBL] [Abstract][Full Text] [Related]
7. Class Ic antiarrhythmics block human skeletal muscle Na channel during myotonia-like stimulation.
Aoike F; Takahashi MP; Sakoda S
Eur J Pharmacol; 2006 Feb; 532(1-2):24-31. PubMed ID: 16473348
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of frog skeletal muscle sodium channels by newly synthesized chiral derivatives of mexiletine and tocainide.
De Luca A; Natuzzi F; Falcone G; Duranti A; Lentini G; Franchini C; Tortorella V; Camerino DC
Naunyn Schmiedebergs Arch Pharmacol; 1997 Dec; 356(6):777-87. PubMed ID: 9453464
[TBL] [Abstract][Full Text] [Related]
9. Homologation of mexiletine alkyl chain and stereoselective blockade of skeletal muscle sodium channels.
Duranti A; Franchini C; Lentini G; Loiodice F; Tortorella V; De Luca A; Pierno S; Conte Camerino D
Eur J Med Chem; 2000 Jan; 35(1):147-56. PubMed ID: 10733611
[TBL] [Abstract][Full Text] [Related]
10. Increased sodium channel use-dependent inhibition by a new potent analogue of tocainide greatly enhances in vivo antimyotonic activity.
De Bellis M; Carbonara R; Roussel J; Farinato A; Massari A; Pierno S; Muraglia M; Corbo F; Franchini C; Carratù MR; De Luca A; Conte Camerino D; Desaphy JF
Neuropharmacology; 2017 Feb; 113(Pt A):206-216. PubMed ID: 27743929
[TBL] [Abstract][Full Text] [Related]
11. Safinamide's potential in treating nondystrophic myotonias: Inhibition of skeletal muscle voltage-gated sodium channels and skeletal muscle hyperexcitability in vitro and in vivo.
Desaphy JF; Farinato A; Altamura C; De Bellis M; Imbrici P; Tarantino N; Caccia C; Melloni E; Padoani G; Vailati S; Keywood C; Carratù MR; De Luca A; Conte D; Pierno S
Exp Neurol; 2020 Jun; 328():113287. PubMed ID: 32205118
[TBL] [Abstract][Full Text] [Related]
12. Mexiletine block of disease-associated mutations in S6 segments of the human skeletal muscle Na(+) channel.
Takahashi MP; Cannon SC
J Physiol; 2001 Dec; 537(Pt 3):701-14. PubMed ID: 11744749
[TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of marketed sodium channel blockers in a rat model of myotonia discloses promising antimyotonic drugs.
Desaphy JF; Carbonara R; Costanza T; Conte Camerino D
Exp Neurol; 2014 May; 255(100):96-102. PubMed ID: 24613829
[TBL] [Abstract][Full Text] [Related]
14. Biophysical characterization of M1476I, a sodium channel founder mutation associated with cold-induced myotonia in French Canadians.
Zhao J; Duprè N; Puymirat J; Chahine M
J Physiol; 2012 Jun; 590(11):2629-44. PubMed ID: 22250216
[TBL] [Abstract][Full Text] [Related]
15. Sea anemone toxin (ATX II) modulation of heart and skeletal muscle sodium channel alpha-subunits expressed in tsA201 cells.
Chahine M; Plante E; Kallen RG
J Membr Biol; 1996 Jul; 152(1):39-48. PubMed ID: 8660409
[TBL] [Abstract][Full Text] [Related]
16. ATX II, a sodium channel toxin, sensitizes skeletal muscle to halothane, caffeine, and ryanodine.
Fletcher JE; Adnet PJ; Reyford H; Wieland SJ; Stewart SL; Rosenberg H
Anesthesiology; 1999 May; 90(5):1294-301. PubMed ID: 10319776
[TBL] [Abstract][Full Text] [Related]
17. Effects of temperature and mexiletine on the F1473S Na+ channel mutation causing paramyotonia congenita.
Fleischhauer R; Mitrovic N; Deymeer F; Lehmann-Horn F; Lerche H
Pflugers Arch; 1998 Oct; 436(5):757-65. PubMed ID: 9716710
[TBL] [Abstract][Full Text] [Related]
18. Effect of mexiletine on long QT syndrome model.
Wang HW; Zheng YQ; Yang ZF; Li CZ; Liu YM
Acta Pharmacol Sin; 2003 Apr; 24(4):316-20. PubMed ID: 12676070
[TBL] [Abstract][Full Text] [Related]
19. Mechanical and electrophysiological effects of sea anemone (Anemonia sulcata) toxins on rat innervated and denervated skeletal muscle.
Alsen C; Harris JB; Tesseraux I
Br J Pharmacol; 1981 Sep; 74(1):61-71. PubMed ID: 6115695
[TBL] [Abstract][Full Text] [Related]
20. Interactions between anemone toxin II and veratridine on single neuronal sodium channels.
Castillo C; Piernavieja C; Recio-Pinto E
Brain Res; 1996 Sep; 733(2):243-52. PubMed ID: 8891307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
